Lobbying Information
Subject Matters
- Health
- Industry
- Intellectual Property
- International Trade
- Science and Technology
Subject Matter Details
Legislative Proposal, Bill or Resolution
- Food and Drugs Act, specifically with respect to the approval, regulation and life-cycle management of therapeutic products
Policies or Program
- Canadian Agency for Drugs and Technologies in Health policies with respect to the Common Drug Review, Health Technology Assessment and the Canadian Optimal Medication Prescribing and Utilization Service
- Federal Health Partnership with respect to the coordination of federal drug plan policies and programs
- Health Canada's "Notice of Compliance with Conditions (NOC/c)" Policy with regard to therapeutic products
- Health benefits programs of Citizenship and Immigration Canada, Correctional Service of Canada, Department of National Defence, Royal Canadian Mounted Police, and Veterans Affairs Canada with respect to decisions and policies that impact reimbursement of therapeutic products for plan beneficiaries.
- International Trade Canada's Invest in Canada policies and programs with respect to investment, business development and innovation in the life sciences industry sector
- Mobilizing Science and Technology to Canada's Advantage, the federal science and technology strategy, with respect to the health and related life sciences and technologies priority area
- Non-Insured Health Benefits Program with respect to decisions and policies that impact reimbursement of therapeutic products for plan beneficiaries
Regulation
- Food and Drugs Act Regulations with respect to Data Protection under C.08.004
- Patent Act Regulations with respect to Patented Medicines (Notice of Compliance) Regulations
- Patent Act as it relates to the regulation of intellectual property for therapeutic products
Communication Techniques
-
Written communication
-
Oral communication
The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.
Government Institutions
-
Citizenship and Immigration Canada
-
Foreign Affairs, Trade and Development Canada
-
Health Canada (HC)
-
House of Commons
-
Industry Canada
-
National Defence (DND)
-
Public Safety Canada (PS)
-
Royal Canadian Mounted Police (RCMP)
-
Senate of Canada
-
Veterans Affairs Canada (VAC)
Client Details
Government funding
No government funding was received during the last completed financial year.
Client Contact Information
Address:
1000 de la Gauchetiere St. W. Suite 500
Montreal, QC H3B 4W5
Canada
Telephone number:
514-844-8515
Client representative
Patrick Cashman, President and General Manager
Parent Company Information
- H. Lundbeck A/S
-
Ottiliavej 9
Copenhagen - Valby DK2500
Denmark
Coalition Members Information
Lundbeck Canada Inc. is not a coalition.
Individual, organization or corporation with a Direct Interest Beneficiary Information
The activities of Lundbeck Canada Inc. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Subsidiary Beneficiary Information
Lundbeck Canada Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyist Details
CARL BALTARE
|
Public offices held
Business address:
50 O'CONNOR ST.
SUITE 901
OTTAWA, ON K1P 6L2
Canada
Telephone number:
613-783-3438
Fax number:
613-782-2426
Consultant Firm and Address
Firm:
GLOBAL PUBLIC AFFAIRS
Address:
50 O'CONNOR ST. SUITE 901
OTTAWA, ON K1P 6L2
Canada
Telephone number:
613-783-3438
Fax number:
613-782-2426
